Plain-English translation of NCT06372717 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This research study is testing a new experimental drug called to see if it can help people with certain types of blood cancer called acute myeloid leukemia and related conditions. Researchers want to find out if this medication is safe and whether it works better when given by itself or combined with other approved cancer drugs that you may have already heard of.
Some people with these blood cancers stop responding to standard treatments or cannot tolerate them. This trial is exploring whether this new medication could offer hope for patients who have limited treatment options left.
You likely qualify if…
You likely don't qualify if…
You would visit the research clinic regularly to receive the medication (by mouth or infusion, depending on which group you join) and have blood tests and heart monitoring to track how the treatment is working and watch for side effects. The trial has different dosing schedules as researchers figure out the safest and most effective dose—some participants take the medication alone, while others receive it combined with one or two other established cancer drugs. Your exact schedule and duration would depend on how you respond and which treatment combination you're assigned to.
AI-generated summary from trial data · Jul 18, 2026 · Not medical advice
Australia